Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

Arizona

Xenoscience Inc.
Phoenix Arizona 85013

Clinical trial for Early Alzheimers

Xenoscience
Phoenix Arizona 85004

Clinical trial for Early Alzheimer's

Xenoscience
Phoenix Arizona 85004

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

UPDATED

Center for NEUROSCIENCES
Tucson Arizona 85718

Clinical trial for Engage + Emerge

Territory Neurology & Research Institute
Tucson Arizona 85704

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

View More ▼

UPDATED

Phoenix Arizona 85006

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Phoenix Arizona 85004

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Phoenix Arizona 85018

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Phoenix Arizona 85013

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Phoenix Arizona 85006

A clinical trial to evaluate treatments using CAD106 Immunotherapy, Placebo to CAD106, CNP520 and Placebo to CNP520 for patients with Alzheimer's Disease

Phoenix Arizona 85013

A clinical trial to evaluate treatments using RVT-101 35 mg and Placebo for patients with Alzheimer's Disease, Dementia With Lewy Bodies or Parkinson's Disease Dementia

Phoenix Arizona 85006

A Phase 2 clinical study for patients with Moderate Alzheimer's Disease

Phoenix Arizona 85013

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Phoenix Arizona 85006

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

UPDATED

Phoenix Arizona 85013

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Phoenix Arizona 85004

A Phase 3 clinical study for patients with Alzheimer's Disease

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study evaluating 18F-AV-1451 for the treatment of Alzheimer's Disease

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study evaluating 18F-AV-1451 for the treatment of Alzheimer's Disease

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study evaluating 18F-AV-1451 for the treatment of Alzheimer's Disease

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease, Early

UPDATED

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of Crenezumab and Placebo to evaluate Alzheimer's Disease, Mild Alzheimer's Disease (AD)

UPDATED

Phoenix Arizona 85004

Patients are needed to participate in a clinical research study of Crenezumab and Placebo to evaluate Alzheimer's Disease, Mild Alzheimer's Disease (AD)

UPDATED

Phoenix Arizona 85020

Patients are needed to participate in a clinical research study of Crenezumab and Placebo to evaluate Alzheimer's Disease, Mild Alzheimer's Disease (AD)

UPDATED

Scottsdale Arizona 85260

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Scottsdale Arizona 85258

A Phase 3 clinical study for patients with Alzheimer's Disease

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of 18F-AV-1451 to evaluate Alzheimer's Disease

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of 18F-AV-1451 to evaluate Alzheimer's Disease

UPDATED

Sun City Arizona 85351

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Sun City Arizona 85351

A clinical trial to evaluate treatments using CAD106 Immunotherapy, Placebo to CAD106, CNP520 and Placebo to CNP520 for patients with Alzheimer's Disease

Sun City Arizona 85351

A Phase 2 clinical study for patients with Moderate Alzheimer's Disease

Sun City Arizona 85351

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Sun City Arizona 85351

Patients are needed to participate in a clinical research study of 18F-AV-1451 to evaluate Alzheimer's Disease

Sun City Arizona 85351

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

UPDATED

Sun City Arizona 85351

Patients are needed to participate in a clinical research study of Crenezumab and Placebo to evaluate Alzheimer's Disease, Mild Alzheimer's Disease (AD)

Tucson Arizona 85741

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Tucson Arizona 85724

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Tucson Arizona 85704

A Phase 2 clinical study for patients with Moderate Alzheimer's Disease

Tucson Arizona 85704

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

UPDATED

Tucson Arizona 85718

A Phase 3 clinical study for patients with Alzheimer's Disease

Tucson Arizona 85718

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease, Early

Arkansas

Fayetteville Arkansas 72703

A clinical research study of Suvorexant 10 mg, Suvorexant 20 mg and Placebo for the treatment of Insomnia or Alzheimer's Disease

UPDATED

Jonesboro Arkansas 72401

A Phase 3 clinical study for patients with Alzheimer's Disease

Little Rock Arkansas 72211

A clinical research study of Suvorexant 10 mg, Suvorexant 20 mg and Placebo for the treatment of Insomnia or Alzheimer's Disease

UPDATED

Springdale Arkansas 72764

A Phase 3 clinical study for patients with Alzheimer's Disease